User: Guest  Login
Document type:
Letter; Research Support, Non-U.S. Gov't; Letter
Author(s):
Fink, A M; Böttcher, S; Ritgen, M; Fischer, K; Pflug, N; Eichhorst, B; Wendtner, C-M; Winkler, D; Bühler, A; Zenz, T; Staib, P; Mayer, J; Hensel, M; Hopfinger, G; Wenger, M; Fingerle-Rowson, G; Döhner, H; Kneba, M; Stilgenbauer, S; Busch, R; Hallek, M
Title:
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
Journal title abbreviation:
Leukemia
Year:
2013
Journal volume:
27
Journal issue:
9
Pages contribution:
1949-52
Language:
eng
Fulltext / DOI:
doi:10.1038/leu.2013.190
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/23787395
Print-ISSN:
0887-6924
TUM Institution:
Institut für Medizinische Statistik und Epidemiologie
 BibTeX